FRM
PTLA
Fox Run Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-15,010
| Closed | -$358K | – | 433 |
|
|
2019
Q4 | $358K | Buy |
+15,010
| New | +$358K | 0.29% | 124 |
|
|
2019
Q3 | – | Sell |
-8,124
| Closed | -$220K | – | 643 |
|
|
2019
Q2 | $220K | Buy |
+8,124
| New | +$220K | 0.15% | 339 |
|
|
2018
Q4 | – | Sell |
-12,308
| Closed | -$328K | – | 831 |
|
|
2018
Q3 | $328K | Sell |
12,308
-16,054
| -57% | -$428K | 0.14% | 320 |
|
|
2018
Q2 | $1.07M | Buy |
+28,362
| New | +$1.07M | 0.34% | 22 |
|
|
2017
Q4 | – | Sell |
-9,700
| Closed | -$524K | – | 974 |
|
|
2017
Q3 | $524K | Buy |
+9,700
| New | +$524K | 0.15% | 278 |
|
|
2016
Q3 | – | Sell |
-21,000
| Closed | -$496K | – | 768 |
|
|
2016
Q2 | $496K | Sell |
21,000
-5,800
| -22% | -$137K | 0.24% | 131 |
|
|
2016
Q1 | $547K | Buy |
+26,800
| New | +$547K | 0.37% | 61 |
|